Natixis Investment Managers International’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-88,235
| Closed | -$31.1M | – | 239 |
|
|
2023
Q2 | $31.1M | Sell |
88,235
-6,225
| -7% | -$2.19M | 2.3% | 18 |
|
|
2023
Q1 | $29.8M | Sell |
94,460
-16,840
| -15% | -$5.31M | 2.25% | 20 |
|
|
2022
Q4 | $32.1M | Sell |
111,300
-14,825
| -12% | -$4.28M | 2.4% | 17 |
|
|
2022
Q3 | $36.5M | Sell |
126,125
-97,650
| -44% | -$28.3M | 2.92% | 14 |
|
|
2022
Q2 | $63.1M | Sell |
223,775
-4,830
| -2% | -$1.36M | 1.28% | 23 |
|
|
2022
Q1 | $59.7M | Sell |
228,605
-26,125
| -10% | -$6.82M | 1.04% | 28 |
|
|
2021
Q4 | $55.9M | Buy |
+254,730
| New | +$55.9M | 3.1% | 15 |
|
|
2018
Q4 | – | Sell |
-7,409
| Closed | -$1.43M | – | 551 |
|
|
2018
Q3 | $1.43M | Buy |
7,409
+2,153
| +41% | +$415K | 0.07% | 270 |
|
|
2018
Q2 | $894K | Sell |
5,256
-4,133
| -44% | -$703K | 0.05% | 304 |
|
|
2018
Q1 | $1.53M | Buy |
+9,389
| New | +$1.53M | 0.11% | 116 |
|
|
2017
Q4 | – | Sell |
-5,142
| Closed | -$782K | – | 349 |
|
|
2017
Q3 | $782K | Buy |
+5,142
| New | +$782K | 0.07% | 204 |
|
|
2015
Q4 | – | Sell |
-3,784
| Closed | -$394K | – | 460 |
|
|
2015
Q3 | $394K | Buy |
3,784
+474
| +14% | +$49.4K | 0.05% | 236 |
|
|
2015
Q2 | $409K | Buy |
3,310
+973
| +42% | +$120K | 0.05% | 244 |
|
|
2015
Q1 | $276K | Buy |
2,337
+934
| +67% | +$110K | 0.04% | 275 |
|
|
2014
Q4 | $167K | Buy |
+1,403
| New | +$167K | 0.02% | 276 |
|